Platelet Aggregation Inhibitors
"Platelet Aggregation Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
| Descriptor ID |
D010975
|
| MeSH Number(s) |
D27.505.954.502.780
|
| Concept/Terms |
Platelet Aggregation Inhibitors- Platelet Aggregation Inhibitors
- Aggregation Inhibitors, Platelet
- Inhibitors, Platelet Aggregation
- Blood Platelet Antiaggregants
- Antiaggregants, Blood Platelet
- Platelet Antiaggregants
- Antiaggregants, Platelet
- Blood Platelet Aggregation Inhibitors
Antiplatelet Agents- Antiplatelet Agents
- Agents, Antiplatelet
- Antiplatelet Drugs
- Drugs, Antiplatelet
Platelet Antagonists- Platelet Antagonists
- Antagonists, Platelet
- Blood Platelet Antagonists
- Antagonists, Blood Platelet
|
Below are MeSH descriptors whose meaning is more general than "Platelet Aggregation Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Platelet Aggregation Inhibitors".
This graph shows the total number of publications written about "Platelet Aggregation Inhibitors" by people in this website by year, and whether "Platelet Aggregation Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 0 | 5 | 5 |
| 2000 | 1 | 2 | 3 |
| 2001 | 4 | 2 | 6 |
| 2002 | 2 | 4 | 6 |
| 2003 | 2 | 1 | 3 |
| 2004 | 4 | 1 | 5 |
| 2005 | 3 | 2 | 5 |
| 2006 | 5 | 2 | 7 |
| 2007 | 1 | 2 | 3 |
| 2008 | 5 | 4 | 9 |
| 2009 | 4 | 7 | 11 |
| 2010 | 3 | 2 | 5 |
| 2011 | 2 | 0 | 2 |
| 2012 | 3 | 3 | 6 |
| 2013 | 3 | 2 | 5 |
| 2014 | 3 | 0 | 3 |
| 2015 | 5 | 0 | 5 |
| 2016 | 7 | 5 | 12 |
| 2017 | 7 | 7 | 14 |
| 2018 | 16 | 3 | 19 |
| 2019 | 8 | 7 | 15 |
| 2020 | 4 | 5 | 9 |
| 2021 | 6 | 7 | 13 |
| 2022 | 2 | 6 | 8 |
| 2023 | 0 | 3 | 3 |
| 2024 | 3 | 4 | 7 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Platelet Aggregation Inhibitors" by people in Profiles.
-
Impact of Perioperative Anticoagulation and Antiplatelet Therapy on Hearing Preservation Outcomes. Otol Neurotol. 2025 Feb 01; 46(2):128-132.
-
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint. Cardiol J. 2025; 32(1):83-89.
-
The impact of postoperative aspirin in patients undergoing Woven EndoBridge: a multicenter, institutional, propensity score-matched analysis. J Neurointerv Surg. 2024 Dec 26; 17(e1):e15-e24.
-
American Society for Gastrointestinal Endoscopy guideline on gastrostomy feeding tubes: summary and recommendations. Gastrointest Endosc. 2025 Jan; 101(1):25-35.
-
Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clin Cardiol. 2024 Oct; 47(10):e70026.
-
A Multicenter Evaluation of Clopidogrel Resistance and Its Role in Predicting Stent Thrombosis in Transcarotid Artery Revascularization. Ann Vasc Surg. 2025 Jan; 110(Pt A):226-232.
-
Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians. Expert Rev Cardiovasc Ther. 2024 Sep; 22(9):483-491.
-
An ISHLT consensus statement on strategies to prevent?and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device. J Heart Lung Transplant. 2024 Aug; 43(8):1199-1234.
-
Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair. J Vasc Surg. 2024 Oct; 80(4):968-978.e3.
-
The Influence of Coagulopathy on Radiographic and Clinical Outcomes in Patients Undergoing Middle Meningeal Artery Embolization as Standalone Treatment for Non-acute Subdural Hematomas. J Neurotrauma. 2024 06; 41(11-12):1375-1383.